Founder of Deciphera Pharmaceuticals, Inc. and Deciphera Pharmaceuticals LLC, Daniel L. Flynn occupies the position of Chief Scientific Officer & Executive VP at Deciphera Pharmaceuticals, Inc. and Director & Chief Scientific Officer at Deciphera Pharmaceuticals LLC (a subsidiary of Deciphera Pharmaceuticals, Inc.).

He previously was Director-Medicinal Chemistry at Amgen, Inc., Principal at Warner-Lambert Co., Senior Director-Chemistry at Millennium Pharmaceuticals, Inc., Director-Medicinal Chemistry at Monsanto Co., Principal at G.D. Searle & Co., Inc., Principal at Parke-Davis Pharmaceutical Research, Inc. and Chairman-Medicinal Chemistry Division at American Chemical Society.

Dr. Flynn received a doctorate and an undergraduate degree from the University of Kansas.